PPAR-gamma in Cushing's disease (Q36369899)

13 August 2017

1 reference

title

PPAR-gamma in Cushing's disease (English)

1 reference

13 August 2017

1 reference

Anthony P Heaney

1

1 reference

13 August 2017

1 January 2004

1 reference

13 August 2017

1 reference

13 August 2017

7

1 reference

13 August 2017

4

1 reference

13 August 2017

265-269

1 reference

https://scigraph.springernature.com/pub.10.1007/s11102-005-1430-8

13 August 2017

0 references

cites work

Transsphenoidal microsurgery for Cushing disease. A report of 216 cases

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11102-005-1430-8

PPARgamma inhibits GH synthesis and secretion and increases apoptosis of pituitary GH-secreting adenomas.

21 January 2018

1 reference

12 December 2020

Effect of pioglitazone on adrenocorticotropic hormone and cortisol secretion in Cushing's disease

1 reference

12 December 2020

Rosiglitazone, PPAR-gamma receptor ligand, decreases the viability of rat prolactin-secreting pituitary tumor cells in vitro

1 reference

12 December 2020

PPAR-gamma receptor ligands: novel therapy for pituitary adenomas

1 reference

12 December 2020

Use of ketoconazole in the treatment of Cushing's disease and ectopic ACTH syndrome

1 reference

12 December 2020

Thiazolidinediones in the treatment of insulin resistance and type II diabetes

1 reference

12 December 2020

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

1 reference

12 December 2020

Pre-operative medical therapy with rosiglitazone in two patients with newly diagnosed pituitary-dependent Cushing's syndrome

1 reference

12 December 2020

Assessment of cure and recurrence after pituitary surgery for Cushing's disease

1 reference

12 December 2020

Molecular targets in pituitary tumours

1 reference

12 December 2020

Differentiation and reversal of malignant changes in colon cancer through PPARgamma

1 reference

12 December 2020

Clinical review 110: Diagnosis and treatment of pituitary tumors

1 reference

12 December 2020

Trends in incidence of primary brain tumors in the United States, 1985-1994.

1 reference

12 December 2020

Acute hypoadrenalism and hepatotoxicity after treatment with ketoconazole

1 reference

12 December 2020

Functional PPAR-gamma receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas

1 reference

12 December 2020

The medical management of Cushing's syndrome

1 reference

12 December 2020

Criteria for cure of acromegaly: a consensus statement

1 reference

12 December 2020

1 reference

12 December 2020

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

1 reference

12 December 2020

Effects of pioglitazone and rosiglitazone on blood lipid levels and glycemic control in patients with type 2 diabetes mellitus: a retrospective review of randomly selected medical records

1 reference

12 December 2020

Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program

1 reference

12 December 2020

Medical therapy of Cushing's disease

1 reference

12 December 2020

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

1 reference

12 December 2020

Long-term follow-up results of transsphenoidal surgery for Cushing's disease in a single centre using strict criteria for remission

1 reference

12 December 2020

Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome

1 reference

12 December 2020

Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors

1 reference

12 December 2020

Serum cortisol response to transsphenoidal surgery for Cushing disease

1 reference

12 December 2020

Peroxisome proliferator-activated receptor gamma and cancers

1 reference

12 December 2020

10.1007/S11102-005-1430-8

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16416039